Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 12, 2008, Pages 1305-1311

  Boonkitticharoen, Vipa ^a   Kulapaditharom, Boonchu ^a   Leopairut, Juvady ^a   Kraiphibul, Puangtong ^a   Larbcharoensub, Noppadol ^a   Cheewaruangroj, Wichit ^a   Chintrakarn, Chalermchai ^a   Pochanukul, Lucksana ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN A;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH CAVITY; PHARYNX; PHARYNX CARCINOMA; PREDICTION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149234928     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.12.1305     Document Type: Article

References (40)

1. Jakobsen J, Hansen O, Jørgensen KE, Bastholt L. Lymph node metastases from laryngeal and pharyngeal carcinomas: calculation of burden of metastasis and its impact on prognosis. Acta Oncol. 1998;37(5):489-493.
2. Dias FL, Lima RA, Kligerman J, et al. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg. 2006;134(3):460-465.
3. Koskinen WJ, Bono P, Leivo I, Vaheri A, Aaltonen LM, Joensuu H. Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression. Radiother Oncol. 2005;77(2):172-175.
4. Thiele W, Sleeman JP. Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol. 2006;124(1):224-241.
5. Lim YC, Koo BS, Lee JS, Lim JY, Choi EC. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for N0 neck. Laryngoscope. 2006;116(7):1148-1152.
6. Stetler-Stevenson WG. Invasion and metastases. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer Principle & Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:113-127.
7. Franchi A, Gallo O, Boddi V, Santucci M. Prediction of occult neck metastasis in laryngeal carcinoma: role of cell proliferating nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res. 1996;2(10):1801-1808.
8. Liu M, Lawson G, Delos M, et al. Prognostic value of cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol. 2003;260(1):28-34.
9. Tisell LE, Oden A, Muth A, et al. The Ki67 index a prognostic marker in medulary thyroid carcinoma. Br J Cancer. 2003;89(11):2093-2097.
10. Myoung H, Kim MJ, Lee YJ, Ok YJ, Paeng JY, Yun PY. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg. 2006;35(11):1005-1010.
11. Orucevic A, Reddy VB, Bloom KJ, et al. Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age. Breast J. 2002;8(6):349-355.
12. Protzel C, Knoedel J, Zimmermann U, Woenckhaus C, Poetsch M, Giebel J. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol. 2007;22(11):1197-1204.
13. Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread: new players begin to emerge. Int J Cancer. 2006;119(8):1755-1760.
14. Strauss L, Volland D, Kunkel M, Reichert TE. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance. Med Sci Monit. 2005;11(8):BR280-BR292.
15. Kikuchi K, Kusama K, Sano M, et al. Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res. 2006;26(3A):1833-1848.
16. Hirakawa S, Kodama S, Kunsfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 2005;201(7):1089-1099.
17. Björndahl MA, Cao R, Burton JB, et al. Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 2005;65(20):9261-9267.
18. Abe A, Fukui H, Fujii S, et al. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion. J Gastroenterol Hepatol. 2007;22(7):1071-1077.
19. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG. Prognostic significance of vascular endothelial growth factor-A, -C and-D in breast cancer and their relationships with angio- and lymphangiogenesis. Br J Cancer. 2007;96(7):1092-1100.
20. Chien CY, Su CY, Hwang CF, Chuang HC, Chen CM, Huang CC. High expressions of CD 105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol. 2006;94(5):413-417.
21. Shang ZJ, Li JR. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. J Oral Pathol Med. 2005;34(3):134-139.
22. Wong YK, Liu CJ, Kwan PC, Chao SY. Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel-associated oral squamous cell carcinoma. J Oral Maxillofac Surg. 2003;61(11):1257-1262.
23. O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlated with lymph node metastasis. Cancer. 2001;92(3):556-568.
24. Mineta H, Miura K, Orgino T, et al. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer. 2000;83(6):775-781.
25. Tímár J, Csuka O, Remenár E, Répássy G, Kásler M. Progression of head and neck squamous cell cancer. Cancer Metastasis Rev. 2005;24(1):107-127.
26. American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002:17-57.
27. Weidner N, Moore DH II, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol. 1994;25(4):337-342.
28. Zar JH. Biostatistical Analysis. 4th ed. Englewood Cliffs, NJ: Prentice-Hall; 1999.
29. Yoshiji H, Harris SR, Thorgeirsson UP. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res. 1997;57(18):3924-3928.
30. Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease. Clin Cancer Res. 2005;11(2, pt 1):584-593.
31. Hanrahan V, Currie MJ, Gunningham P, et al. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol. 2003;200(2):183-193.
32. Fujiwaki R, Hata K, Iida K, Maede Y, Miyazaki K. Vascular endothelial growth factor expression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumour cell proliferation, and apoptosis. Anticancer Res. 2000;20(2B):1317-1322.
33. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med. 2001;7(2):186-191.
34. Gannon G, Mandriota SJ, Cui L, Baetens D, Pepper MS, Christofori G. Overexpression of vascular endothelial growth factor-A 165 enhances tumor angiogenesis but not metastasis during β-cell carcinogenesis. Cancer Res. 2002;62(2):603-608.
35. Kondo K, Kaneko T, Baba M, Konno H. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull. 2007;30(4):633-637.
36. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res. 2000;6(6):2431-2439.
37. Skobe M, Detmar M. Structure, function and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc. 2000;5(1):14-19.
38. Khafif RA, Gelbfish GA, Tepper P, Attie JN. Elective radical dissection in epidermoid cancer of the head and neck: a retrospective analysis of 853 cases of mouth, pharynx, and larynx cancer. Cancer. 1991;67(1):67-71.
39. Manni JJ, van den Hoogen FJ. Supraomohyoid neck dissection with frozen section biopsy as a staging procedure in clinically node-negative neck in carcinoma of the oral cavity. Am J Surg. 1991;162(4):373-376.
40. Wei WI, Ferlito A, Rinaldo A, et al. Management of the N0 neck: reference or preference. Oral Oncol. 2006;42(2):115-122.